U.S. patent application number 16/707364 was filed with the patent office on 2020-04-16 for intravenous bag and line label.
The applicant listed for this patent is PharMEDium Services, LLC. Invention is credited to Daane E. Hoffman, Steven M. Maraone, Jeffrey S. Nordquist.
Application Number | 20200118468 16/707364 |
Document ID | / |
Family ID | 65038130 |
Filed Date | 2020-04-16 |
United States Patent
Application |
20200118468 |
Kind Code |
A1 |
Nordquist; Jeffrey S. ; et
al. |
April 16, 2020 |
INTRAVENOUS BAG AND LINE LABEL
Abstract
A label for use with an intravenous bag having a surface and an
interior volume for holding a solution in fluid communication with
an intravenous line for dispensing the solution, where the label
includes a back layer including an adhesive for securing the label
to a surface of the intravenous bag, a front layer with a solution
name including a first portion secured to the back layer, the front
layer including a second portion removable from the back layer
engageable with the intravenous line with the solution name on a
first side and a second side. In some constructions, the solution
name on the second side is inverted with respect to the solution
name on the first side, and the second portion further includes an
opening for viewing a portion of the intravenous line when the
second portion is engaged with the intravenous line.
Inventors: |
Nordquist; Jeffrey S.; (Lake
Barrington, IL) ; Maraone; Steven M.; (Lake Zurich,
IL) ; Hoffman; Daane E.; (Winthrop Harbor,
IL) |
|
Applicant: |
Name |
City |
State |
Country |
Type |
PharMEDium Services, LLC |
Lake Forest |
IL |
US |
|
|
Family ID: |
65038130 |
Appl. No.: |
16/707364 |
Filed: |
December 9, 2019 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
16451578 |
Jun 25, 2019 |
10504387 |
|
|
16707364 |
|
|
|
|
16053091 |
Aug 2, 2018 |
10373530 |
|
|
16451578 |
|
|
|
|
62539199 |
Jul 31, 2017 |
|
|
|
Current U.S.
Class: |
1/1 |
Current CPC
Class: |
B32B 1/00 20130101; A61M
2205/60 20130101; A61J 2205/10 20130101; A61M 5/1414 20130101; A61J
1/1475 20130101; G09F 2003/0229 20130101; A61M 2205/6063 20130101;
G09F 3/0295 20130101; G09F 2003/0222 20130101; A61J 2205/30
20130101; G09F 2003/0269 20130101; A61M 5/14 20130101; G09F 3/0288
20130101; G09F 3/10 20130101; G09F 2003/0201 20130101; A61M
2205/6009 20130101; A61J 2205/20 20130101; A61J 1/10 20130101; A61J
2205/60 20130101 |
International
Class: |
G09F 3/10 20060101
G09F003/10; G09F 3/00 20060101 G09F003/00; A61J 1/10 20060101
A61J001/10; A61M 5/14 20060101 A61M005/14; B32B 1/00 20060101
B32B001/00; A61J 1/14 20060101 A61J001/14 |
Claims
1. A label for use with an intravenous bag having a surface and an
interior volume for holding a solution in fluid communication with
an intravenous line for dispensing the solution, the label
comprising: a back layer including an adhesive for securing the
label to a surface of the intravenous bag; and a front layer
including: a first portion secured to the back layer displaying a
solution name, and a second portion removable from the back layer
and engageable with the intravenous line, the second portion
including the solution name on a first side and a second side, the
solution name on the second side inverted with respect to the
solution name on the first side, and an opening for viewing a
portion of the intravenous line when the second portion is engaged
with the intravenous line.
2. The label of claim 1, wherein the second portion is foldable
about the intravenous line to secure the second portion to the
intravenous line and wherein the first side and the second side
display the solution name when the second portion is engaged with
the intravenous line.
3. The label of claim 1, wherein at least a portion of a back of
the second portion has an adhesive proximate the opening.
4. The label of claim 1, wherein the second portion has rounded
corners.
5. The label of claim 1, wherein the opening has a width that is
larger than a circumference of the intravenous line.
6. The intravenous solution delivery system of claim 5, wherein a
portion of the intravenous line is visible through the opening when
the second portion is positioned along the intravenous line.
7. The label of claim 1, wherein a slit is formed between the first
portion and the second portion.
8. An intravenous solution delivery system comprising: an
intravenous bag including a surface and an interior volume adapted
to receive a solution; an intravenous line engaged with the
intravenous bag and configured to dispense the solution; a label
attached to the intravenous bag, the label including: a back layer
including an adhesive for securing the label to a surface of the
intravenous bag; and a front layer including: a first portion
secured to the back layer and including a solution name, and a
second portion removable from the back layer and engageable with
the intravenous line, the second portion including the solution
name on a first side and a second side, the solution name on the
second side inverted with respect to the solution name on the first
side, and an opening for viewing a portion of the intravenous line
when the second portion is engaged with the intravenous line.
9. The intravenous solution delivery system of claim 8, wherein the
second portion is foldable about the intravenous line to secure the
second portion to the intravenous line and the first side and the
second side display the name of the solution when the second
portion is engaged with the intravenous line.
10. The intravenous solution delivery system of claim 8, wherein a
width of the opening is larger than a circumference of the
intravenous line.
11. The intravenous solution delivery system of claim 10, wherein a
portion of the intravenous line is visible through the opening when
the second portion is positioned along the intravenous line.
12. The intravenous solution delivery system of claim 8, wherein a
perforated line is formed between the first portion and the second
portion.
13. A method of labeling an intravenous line engaged with an
intravenous bag including a surface and defining an interior volume
for receiving a solution, the method comprising: providing a label
including: a back layer including an adhesive for securing the
label to a surface of the intravenous bag; and a front layer
including: a first portion secured to the back layer and including
a solution name, and a second portion removable from the back layer
and engageable with the intravenous line, the second portion
including the solution name on a first side and a second side, the
solution name on the second side inverted with respect to the
solution name on the first side, and an opening for viewing a
portion of the intravenous line when the second portion is engaged
with the intravenous line, engaging the label with the surface of
the intravenous bag; detaching the second portion of the label from
the first portion of the label; aligning the opening of the second
portion along the intravenous line; and folding the second portion
about the intravenous line to secure the second side to the first
side so that the first side and the second side display the name of
the solution.
14. The label of claim 13, further comprising the step of viewing a
portion of the intravenous line through the opening when the second
portion is positioned along the intravenous line.
15. A method of printing an intravenous bag label for use with an
intravenous bag engageable with an intravenous line comprising:
selecting with a user interface a solution name from a solution
information database stored in a memory a control system;
responsive to selecting the solution name, retrieving printing
instructions from the solution information database, the printing
instructions including the identification of a type of a roll of
labels upon which to print the solution name and selecting the
identified roll; aligning the selected roll of labels with a
printing member of the label printer, the roll of labels including
a backing sheet having a machine-readable label identifying the
type of the selected roll of labels; scanning the machine-readable
label on the roll of labels to confirm the type of the roll of
labels; and printing at least one label of the roll of labels
according to the printing instructions.
16. The method of claim 15, wherein the at least one label on the
roll of labels includes: a back layer including an adhesive for
securing the label to a surface of the intravenous bag; and a front
layer including: a first portion secured to the back layer and
including a solution name, and a second portion removable from the
back layer and engageable with the intravenous line, the second
portion including the solution name on a first side and a second
side, the solution name on the second side inverted with respect to
the solution name on the first side, and an opening for viewing a
portion of the intravenous line when the second portion is engaged
with the intravenous line.
17. The method of claim 15, wherein the type of labels includes a
color-coded upper portion.
18. The method of claim 15, wherein the type of labels includes a
risk indicator.
19. The method claim 15, wherein the machine-readable label is
off-center with respect to a backing of the roll of labels and
generally parallel to a longitudinal extent of the backing.
Description
CROSS-REFERENCE TO RELATED APPLICATION(S)
[0001] This application is a continuation of U.S. patent
application Ser. No. 16/451,578, filed on Jun. 25, 2019, which is a
divisional of U.S. patent application Ser. No. 16/053,091, filed on
Aug. 2, 2018, issued as U.S. Pat. No. 10,373,530 on Aug. 6, 2019,
which claims priority to U.S. Provisional Patent Application No.
62/539,199, filed on Jul. 31, 2017, the entire contents of each of
which are fully incorporated herein by reference.
BACKGROUND
[0002] The present disclosure relates to a system for ensuring
accuracy of printed labels for intravenous bags and for intravenous
lines engaged with the intravenous bags.
[0003] In the healthcare industry, solutions, such as diluent
solutions, such as saline solutions or dextrose solutions, or
solutions including pharmaceutical compounds, such as compounded
drugs, may be administered to a patient intravenously. A solution
to be administered intravenously is packaged within an intravenous
bag and dispensed to the patient through an intravenous line
engaged with the intravenous bag.
[0004] Intravenous bags are typically labeled with information
identifying a name of the solution, for example a name of the
diluent or a name of the pharmaceutical compound in the solution.
Color-coded labels, color-coded risk indicators, and TALLman
letters are often used to assist healthcare professionals in
quickly and accurately identifying the solution dispensed from each
of the intravenous bags.
[0005] A patient may be simultaneously treated with multiple
intravenously-delivered solutions. Each solution is delivered from
an intravenous bag through a dedicated intravenous line. The
intravenous lines engaged with the intravenous bags are often also
labeled with the name of the solution to avoid confusion between
lines from different bags, for example when changing intravenous
bags or inspecting intravenous lines. However, the intravenous line
labels are typically provided separately from the intravenous bag
labels, which could lead to mislabeling of the intravenous line.
Furthermore, the intravenous line label may block the labeled
portion of the intravenous line, preventing a healthcare provider
from noticing air bubbles, discoloration, blockages, or other
abnormalities present in the labeled portion of the intravenous
line.
SUMMARY
[0006] The present disclosure relates to a labeling system that
reduces the likelihood of label printing errors and mismatched
intravenous bag and intravenous line labels. The labeling system of
the present disclosure provides a label in which a bag label
portion and a line label portion are printed onto a shared backing.
The bag label portion is fixed to the shared backing and the line
label portion is removably attached to the shared backing, enabling
the line label to be removed from the liner and secured to an
intravenous bag as a single unit. The removable intravenous line
label may also include an opening that allows visualization of the
labeled portion of the intravenous line. This opening enables a
healthcare provider to inspect the labeled intravenous line at the
point of attachment of the line label for air bubbles,
discoloration, blockages, or other issues in the fluid flowing
through the labeled portion of the intravenous line.
[0007] In one construction, the disclosure provides a label for use
with an intravenous bag having a surface and an interior volume for
holding a solution. The intravenous bag is in fluid communication
with an intravenous line for dispensing the solution. The label
includes a back layer including an adhesive for securing the label
to a surface of the intravenous bag. The label further includes a
front layer including a first portion secured to the back layer and
including a solution name. The front label in turn includes a
second portion removable from the back layer and engageable with
the intravenous line. The second portion includes the solution name
on a first side and a second side. The solution name on the second
side is inverted with respect to the solution name on the first
side. The second portion may also include an opening for viewing a
portion of the intravenous line when the second portion is engaged
with the intravenous line. In another construction, the solution
name on the second side is not inverted with respect to the
solution name on the first side.
[0008] In another construction, the disclosure provides an
intravenous solution delivery system including an intravenous bag
having a surface and an interior volume adapted to receive a
solution. The intravenous solution delivery system also includes an
intravenous line engaged with the intravenous bag for dispensing
the solution. The intravenous solution delivery system further
includes a label attached to the intravenous bag. The label
includes a back layer having an adhesive for securing the label to
a surface of the intravenous bag. The label further includes a
front layer including a first portion secured to the back layer and
including a solution name. The front layer further includes a
second portion removable from the back layer and engageable with
the intravenous line. The second portion includes the solution name
on a first side and a second side. The solution name on the second
side is inverted with respect to the solution name on the first
side. The second portion may also include an opening for viewing a
portion of the intravenous line when the second portion is engaged
with the intravenous line. In another construction, the solution
name on the second side is not inverted with respect to the
solution name on the first side.
[0009] In another construction, the disclosure provides a method of
labeling an intravenous line engaged with an intravenous bag
including a surface and defining an interior volume for receiving a
solution. The method includes providing a label including a back
layer including an adhesive for securing the label to a surface of
the intravenous bag a front layer including a first portion secured
to the back layer and including a solution name. The front layer
further includes a second portion removable from the back layer and
engageable with the intravenous line. The second portion has the
solution name on a first side and a second side. The solution name
on the second side is inverted with respect to the solution name on
the first side. The second portion may also include an opening for
viewing a portion of the intravenous line when the second portion
is engaged with the intravenous line. The method further includes
engaging the label with the surface of the intravenous bag;
detaching the second portion of the label from the first portion of
the label; aligning the opening of the second portion along the
intravenous line; and folding the second portion about the
intravenous line to secure the second side to the first side so
that the first side and the second side display the name of the
solution.
[0010] In another construction, the disclosure provides a method of
printing an intravenous bag label for use with an intravenous bag
engageable with an intravenous line. The method includes selecting
a solution name from a solution information database stored in a
memory of a label printer. In response to selecting the solution
name, the method further includes retrieving printing instructions
from the solution information database. The printing instructions
include a type of a roll of labels upon which to print the solution
name. The method further includes aligning the roll of labels with
a printing member of the label printer. The roll of labels includes
a backing sheet having a machine-readable label including a type of
the roll of labels. The method further includes scanning the
machine-readable label on the roll of labels to confirm the type of
the roll of labels. The method further includes printing at least
one label of the roll of labels according to the printing
instructions.
[0011] Other aspects of the disclosure will become apparent by
consideration of the detailed description and accompanying
drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
[0012] FIG. 1 is a perspective view of an intravenous bag labeling
system engaged with an intravenous bag.
[0013] FIG. 2 is a view of a portion of a roll of intravenous bag
labels that includes the intravenous bag labels of FIG. 1 before
printing according to one construction.
[0014] FIG. 3 is an exploded view of the intravenous bag label of
FIG. 2.
[0015] FIG. 4 is a detail view of a line label portion of the
intravenous bag label of FIG. 2 according to one construction.
[0016] FIG. 5 is a detail view of a line label portion of the
intravenous bag label of FIG. 2 according to another
construction.
[0017] FIG. 6 is a detail view of a line label portion the
intravenous bag label of FIG. 2 according to another
construction.
[0018] FIG. 7 is a perspective view of an intravenous line portion
of the intravenous bag label of FIG. 2 aligned with an intravenous
line.
[0019] FIG. 8 is a perspective view of an intravenous line portion
of the intravenous bag label of FIG. 2 engaged with an intravenous
line.
[0020] FIG. 9 is a schematic representation of a printing machine
for printing the intravenous bag label of FIG. 2 according to some
constructions.
DETAILED DESCRIPTION
[0021] Before any constructions of the disclosure are explained in
detail, it is to be understood that the disclosure is not limited
in its application to the details of construction and the
arrangement of components set forth in the following description or
illustrated in the following drawings. The disclosure is capable of
other constructions and of being practiced or of being carried out
in various ways. In any disclosed construction, the term
"approximately" may be substituted with "within a percentage of"
what is specified, wherein the percentage includes 0.1, 1, 5, and
10 percent.
[0022] FIG. 1 illustrates an intravenous bag 10 that includes an
intravenous bag label 14, a hanger hole 18, an internal volume 22,
a medication port 26, and an intravenous line port 30. The
intravenous bag label 14 includes a bag label 34 and a line label
38. In the illustrated construction, the intravenous bag label 14
is mounted on a front face 42 of the intravenous bag 10. A similar
or identical label may be attached to the back face (not shown) of
the intravenous bag 10. The hanger hole 18 is positioned proximate
a top of the intravenous bag 10 for mounting the intravenous bag 10
on an intravenous bag pole (not shown). The internal volume 22
receives a solution for administration to a patient. The medication
port 26 is positioned proximate a bottom of the intravenous bag 10.
The medication port 26 allows a healthcare provider to add
medication to the solution inside the internal volume 22. The
intravenous line port 30 is positioned proximate the bottom of the
intravenous bag 10. The intravenous line port 30 receives an
intravenous line 46 for administering the solution to the
patient.
[0023] As shown in FIGS. 1 and 2, the bag label 34 may include an
upper portion 50 and a lower portion 54. The upper portion 50 of
the bag label 34 and/or the intravenous line label 38 may be
color-coded to assist a user in identifying the solution stored in
the intravenous bag 10. The upper portion 50 may also include
information such as a name 58 of the solution, a total dose of the
solution, or a concentration of the solution, and a total volume of
the solution. The lower portion 54 may include a risk indicator 62
to alert a user to a risk characteristic of the drug, such as the
"high alert" indicator 62 shown positioned beneath the upper
portion 50 in FIG. 1. The label lower portion 54 may also include
identifying information such as a lot number of the solution, a
packaging date of the solution, and an expiration date of the
solution. The lower portion 54 may also include a machine-readable
label 66 that includes identifying information about the solution
stored in the intravenous bag 10. Exemplary identifying information
may include the name 58 of the solution, the dose or the
composition of the solution, the total volume of the solution, the
lot number of the solution, the expiration date of the solution,
and/or the packing date of the solution. In the construction
illustrated in FIG. 1, the machine-readable label 66 is a barcode.
In other constructions, the machine-readable label 66 may be an
RFID tag embedded in the intravenous bag label 14. In some
constructions, the intravenous bag label 14 may be made from a
material that may be written-upon by a user.
[0024] As illustrated in FIG. 3, the bag label 34 is attached to a
carrier sheet 70. The carrier sheet 70 is affixed to the front face
42 of the intravenous bag 10 with an adhesive (not shown) that
ensures that the carrier sheet 70 cannot easily be removed from the
intravenous bag 10 (FIG. 1). The carrier sheet 70 is longer than
the bag label 34. Since the carrier sheet 70 is longer than the bag
label 34, a portion 74 of the carrier sheet 70 extends beyond an
end 78 of the bag label 34. The line label 38 may be attached to
the portion 74 of the carrier sheet 70 that extends beyond the end
78 of the bag label 34. The line label 38 may be removed from the
portion 74 of the carrier sheet 70 without disturbing the bag label
34 when the intravenous bag labeling system 14 is secured to the
intravenous bag 10. In the illustrated construction, the bag label
34 and the line label 38 may be separated by a slit 82. The line
label 38 may include a marking 106 (FIGS. 4-5) proximate the slit
82 to encourage a user to remove the line label 38 from the bag
label 34. In other constructions, the bag label 34 and the line
label 38 are separated by a perforated line. To facilitate removal
of the line label 38, in some constructions, at least some of the
portion 74 of the carrier sheet 70 that extends beyond the end 78
of the bag label 34 may include a non-stick coating. In some
constructions, the entire portion 74 includes a non-stick
coating.
[0025] As is best shown in FIGS. 4-6, the line label 38 includes a
first portion 90 and a second portion 94. The name 58 of the
solution stored in the internal volume 22 of the intravenous bag 10
is printed on the front of the first portion 90 and the front of
the second portion 94. In the construction illustrated in FIGS. 4
and 5, the name 58 printed on the second portion 94 is inverted
with respect to the name 58 printed on the first portion 90. The
name 58 of the solution is therefore readable by a user from above
or below the line label 38 when the line label 38 is engaged with
the intravenous line 46. In some constructions, such as shown in
FIG. 6, the name 58 printed on the second portion 94 is not
inverted with respect to the name 58 printed on the first portion
90. At least a portion of the back of the first portion 90 or the
back of the second portion 94 of the line label 38 includes an
adhesive (not shown). When the line label 38 is secured to the
intravenous line 46 (FIG. 8), the adhesive secures the back of the
first portion 90 to the back of the second portion 94. A portion of
the adhesive may engage the intravenous line 46 to reduce slipping
of the line label 38 along the intravenous line 46. As is best
shown in FIGS. 4-8, the removable line label 38 has rounded corners
98 to reduce possible patient discomfort should the label rub
against a patient when the line label 38 is engaged with the
intravenous line 46. In the illustrated construction, the rounded
corners 98 of the line label 38 are formed by die-cutting. In some
constructions, a central axis 110 of the opening 102 shown with a
line 114 positioned to assist a user in aligning the line label 38
with the intravenous line 46. The line label 38 may be removed from
the intravenous line 46. For example, a healthcare practitioner may
tear the line label 38 off of the intravenous line 46 after the
patient has stopped being treated with the solution in the
intravenous bag 10.
[0026] In some constructions, such as the constructions of FIGS. 4
and 6-8, the line label 38 may include an opening 102. The opening
102 preferably has a width 108 longer than a circumference of the
intravenous line 46. The intravenous line 46 is therefore visible
when the line label 38 is engaged with the intravenous line 46. The
opening 102 allows the user to check for air bubbles,
discoloration, or any other abnormalities in the intravenous line
46 while the line label 38 is engaged with the intravenous line 46.
As shown in FIG. 4, the opening 102 may be substantially centered
along the line label 38. In other constructions, the opening 102
may be off-center along the line label 38. In the illustrated
construction, the opening 102 is formed by die-cutting.
[0027] Referring again to FIG. 2, the unitary construction of the
intravenous bag label 14 enables the line label 38 to be printed at
the same time as the bag label 34 is printed, which reduces the
likelihood that the intravenous line 46 could be mislabeled. In
constructions in which the intravenous bag label 14 is printed
using a label printing machine 126, intravenous bag labels 14 that
have not yet been printed with the solution name 58 may be provided
on a backing sheet 118. The backing sheet 118 may be rolled into a
spool of unprinted intravenous bag labels 14. The intravenous bag
labels 14 may include color coding on the upper portion 50, the
lower portion 54, and/or the risk indicator 62 printed on the lower
portion 54. The backing sheet 118 of each roll may include a
machine-readable label 122 (FIG. 2) that includes data about any
color coding or indicia pre-printed on the intravenous bag labels
14. In the illustrated construction, the machine-readable label 122
is generally perpendicular to a longitudinal extent of the backing
sheet 118 and offset from a center of a width of the backing sheet
118. In the illustrated construction, the machine-readable label
122 is printed on a front side (e.g. the side including the
intravenous bag labels 14) of the backing sheet 118. In other
constructions, the machine-readable label may be printed on a back
side of the backing sheet 118. In the illustrated construction, the
machine-readable label 122 is a barcode including a roll stock
number of the roll of intravenous bag labels 14. The rolls of
intravenous bag labels 14 may be used with the label printing
machine 126.
[0028] With reference to FIG. 9, the label printing machine 126
includes a control system 130, a user interface 134, a label reader
138, and a printer 142. In some constructions, the control system
130 is included the label printing machine 126. In other
constructions, the control system may be included in a computing
device that is in electronic communication with the label printing
machine. The control system 130 includes a processor 146 and a
memory 150. The memory 150 includes a solution information database
154. The solution information database 154 includes information
that must be printed on the intravenous bag labels 14 for each
solution that could be stored in and dispensed from the intravenous
bag 10. For example, the solution information database 154 may
include information such as the name 58 of the drug or solution,
the dose or the composition of the solution, the total volume of
the solution, the expiration date of the solution, the lot number
of the solution, and any other information required by labelling
standards. The solution information database 154 may also include
label printing instructions that may specify a specific color code
or risk indicator 62 that must be included on the intravenous bag
labels 14. In the illustrated construction, the label printing
machine 126 is adapted to receive preprinted rolls of intravenous
bag labels 14 that include color coding and alert indicia. The
label printing machine 126 may also receive rolls of intravenous
bag labels 14 that are not pre-printed with color coding or risk
indicators 62.
[0029] In operation, a user verifies the solution name 58 for
printing onto the intravenous bag label 14 or to print onto
multiple intravenous bag labels 14. The user enters the solution
name 58 into user interface 134 of the label printing machine 126,
for example by scanning a machine-readable label including the
solution name 58 and the barcode roll stock number 14 with the
label reader 138 of the label printing machine 126. In response to
receiving the solution name 58, the control system 130 retrieves
the information that must be printed onto the intravenous bag label
14 from the solution information database 154. The label reader 138
then reads the machine-readable label 122 printed on the backing
sheet 118 to ensure that the correct roll of intravenous bag labels
14 has been aligned with the printer 142. The machine-readable
label 122 may also be scanned with a manual label reader (not
shown) and a user may manually verify that the correct roll of
intravenous bag labels 14 is being used. The printer 142 then
prints the drug information onto the intravenous bag labels 14. In
some constructions, the label reader 138 periodically checks the
machine-readable label 122 printed on the backing sheet 118 to
verify that the correct roll of intravenous bag labels 14 is being
is used. Since the bag label 34 and the line label 38 are formed of
a unitary intravenous bag label 14, both the bag label 34 and the
line label 38 are printed at the same time. Accordingly, both the
bag label 34 and the line label 38 include the name 58 of the same
solution. In some constructions, the bag label 34 and the line
label 38 may include other identifying information about the
solution.
[0030] In operation, the intravenous bag label 14 is removed from
the backing sheet 118 (e.g. on a spool or on a sheet of labels) as
a single unit. The intravenous bag label 14 is then secured to the
face 42 of the intravenous bag 10. In some constructions, the
intravenous bag 10 has been filled with the same solution name as
the solution name 58 printed on the intravenous bag label 14. In
other constructions, the intravenous bag 10 will be filled with the
same solution as the solution name 58 printed on the intravenous
bag label 14. The internal volume 22 is then filled with the
intravenous bag 10 with the solution that is printed on the
intravenous bag label 14. The filled and labeled intravenous bag 10
is bagged for transportation to an end user, such as a healthcare
worker. In some constructions, a second intravenous line label 14
may be secured to the intravenous bag 10, for example at a face on
an opposite side of the intravenous bag 10 than the face 45.
[0031] When the intravenous bag 10 is deployed by a healthcare
worker for use with a patient, the healthcare worker secures an end
of intravenous line 46 to the intravenous bag 10. The healthcare
worker then detaches the line label 38 from the bag label 34 by
peeling the line label 38 away from the carrier sheet 70 along the
slit 82. The healthcare worker then aligns the central axis 110 of
the line label 38 with the intravenous line 46 as is shown in FIG.
7. In constructions in which two intravenous line labels 14 are
secured to the intravenous bag 10, the healthcare worker may
position one of the intravenous bag labels 14 on a portion of the
intravenous line 46 that is proximate the intravenous bag 10 and
one of the intravenous bag labels 14 on a portion of the
intravenous line 46 that is (or will be) proximate the patient. The
healthcare worker then folds the line label 38 about the
intravenous line 46 so that the adhesive secures the back surface
of the first portion 90 to the back surface of the second portion
94 to secure the line label 38 to the intravenous line 46. When the
line label 38 is secured to the intravenous line 46, the line label
38 displays the name 58 of the solution on the intravenous line 46.
In constructions having the opening 102, the healthcare worker may
inspect the intravenous line 46 through the opening 102. In
constructions in which the intravenous bag label 14 is made by a
material that may be written upon, the healthcare worker may write
upon on the intravenous bag label 14. For example, the healthcare
worker may write a date and a time at which the intravenous
treatment started upon the intravenous bag label 14.
[0032] Various features and advantages of the disclosure are set
forth in the following claims.
* * * * *